Translational Services

Advancing cell and gene therapies from discovery to clinic

Meaningful drug candidate selection requires reliable proof-of-concept data to streamline the path from discovery to clinic. As regulatory requirements continue to evolve for cell and gene therapies and identifying suitable raw materials early becomes more indicative of success in clinic, ensuring your candidate has a strong potential to quickly and easily translate to GMP-environments can save time and costs in future process development.

Patheon Translational Services include custom molecular biology (cloning, plasmid DNA constructs), viral vector packaging (LV, AAV), and cell therapy services that utilize established scalable processes with advanced analytical testing representative of future cGMP workflows. Leverage an experienced team of scientists with over 20 years of cGMP manufacturing and technical experience to accelerate product development and facilitate a smooth transition to the clinic.

With Patheon Translational Services you’ll experience:

Translational Services generates materials for research use only. Not for IND-enabling studies or diagnostics purposes.

Learn how Translational services can support your path to clinical development with reliable proof-of-concept data.

Related Sites

Additional Resources